3422 J. Med. Chem. 2010, 53, 3422–3422
Corrections to Discovery and Clinical Evaluation of 1-{N-[2-(Amidinoaminooxy)ethyl]amino}carbonylmethyl-6methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (RWJ671818), a Thrombin Inhibitor with an Oxyguanidine P1 Motif [J. Med. Chem. 2010, 53, 1843. DOI: 10.1021/jm901802n]. Tianbao Lu, Thomas Markotan, Shelley K. Ballentine, Edward C. Giardino, John Spurlino, Carl S. Crysler, Kathryn Brown, Bruce E. Maryanoff, Bruce E. Tomczuk, Bruce P. Damiano, Umesh Shukla, David End, Patricia Andrade-Gordon, Roger F. Bone, and Mark R. Player* Page 1843. An author was missing from the byline. The complete author listing is indicated above and also outlined below: Tianbao Lu, Thomas Markotan, Shelley K. Ballentine, Edward C. Giardino, John Spurlino, Carl S. Crysler, Kathryn Brown, Bruce E. Maryanoff, Bruce E. Tomczuk, Bruce P. Damiano, Umesh Shukla, David End, Patricia Andrade-Gordon, Roger F. Bone, and Mark R. Player DOI: 10.1021/jm100354s Published on Web 03/24/2010
